Tango Therapeutics Reports Second Quarter 2023 Financial …
https://ir.tangotx.com/news-releases/news-release-details/tango-therapeutics-reports-second-quarter-2023-financial-results
WEBBOSTON, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, reported its financial results for the second quarter ended June 30, 2023, and provided business highlights.
DA: 65 PA: 89 MOZ Rank: 95